CRONOS GROUP INC. Proceeds from Sale of Equity Method Investments
CRONOS GROUP INC. (CRON) reported Proceeds from Sale of Equity Method Investments of $1.42 million for the 12-month period ending 2019-12-31, per its 10-K/A filed 2020-03-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfEquityMethodInvestments · last filed 2020-03-30
- CRONOS GROUP INC. proceeds from sale of equity method investments for fiscal 2019 was $1.42M.
| Period end | Proceeds from Sale of Equity Method Investments 12 month |
|---|---|
| 2019-12-31 | $1.42M 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |